{"id":2710,"date":"2022-05-19T13:00:00","date_gmt":"2022-05-19T13:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/"},"modified":"2022-05-19T13:00:00","modified_gmt":"2022-05-19T13:00:00","slug":"chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/","title":{"rendered":"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Sjukhuset CHU Toulouse i Frankrike har nu introducerat program f\u00f6r maskinperfusion f\u00f6r b\u00e5de lever och lunga. I och med det \u00e4r det m\u00f6jligt f\u00f6r dem att signifikant \u00f6ka antalet transplantationer. Under ett normalt \u00e5r utf\u00f6r sjukhuset cirka 45 levertransplantationer och cirka 20 lungtransplantationer och d\u00e4rmed uppfyller de redan den lokala kravpolicyn f\u00f6r organtransplantation. De nya programmen f\u00f6r maskinperfusion \u00f6ppnar ocks\u00e5 upp f\u00f6r anv\u00e4ndning av organ som donerats efter cirkulationsstillest\u00e5nd (DCD).<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Frankrike \u00e4r den n\u00e4st st\u00f6rsta transplantationsmarknaden i Europa. Under 2020 genomf\u00f6rdes 1 112 levertransplantationer och 291 lungtransplantationer. Trots detta \u00f6verstiger v\u00e4ntelistan f\u00f6r en ny lever eller lunga l\u00e5ngt antalet tillg\u00e4ngliga organ. Maskinperfusion \u00e4r en innovativ och bepr\u00f6vad teknik f\u00f6r att bevara och utv\u00e4rdera organ, vilket leder till att fler donerade organ blir godk\u00e4nda f\u00f6r transplantation.<\/p>\n<p>En nyligen publicerad artikel i American Journal of Transplantation, d\u00e4r man anv\u00e4nde XVIVOs Liver Assist, visade att man kan genomf\u00f6ra transplantationer av organ som initialt hade valts bort med utm\u00e4rkta resultat. Detta indikerar att maskinperfusion en effektiv teknologi f\u00f6r att \u00f6ka antalet l\u00e4mpliga organ f\u00f6r transplantation. I studien kombinerades tv\u00e5 vanliga protokoll f\u00f6r maskinperfusion av lever<a href=\"http:\/\/#_ftn1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a>.<\/p>\n<p>&#34;Att introducera tv\u00e5 program f\u00f6r maskinperfusion inneb\u00e4r att fler patienter kommer f\u00e5 den livsf\u00f6r\u00e4ndrande v\u00e5rd de beh\u00f6ver. M\u00f6jligheten att utv\u00e4rdera organ utanf\u00f6r kroppen \u00e4r extremt v\u00e4rdefullt, vilket inte \u00e4r m\u00f6jligt med traditionell kall f\u00f6rvaring av organ. Som en drivande kraft i programmet f\u00f6r ex vivo lungperfusion tror jag personligen att vi kommer f\u00f6rkorta tiden f\u00f6r patienter p\u00e5 v\u00e4ntelistan nu n\u00e4r fler organ kan anv\u00e4ndas. Inledningsvis f\u00f6rv\u00e4ntar vi oss en \u00f6kning av lungtransplantationer med 20 procent\u201d, s\u00e4ger Pierre Rabinel, MD Thoracic Surgery vid CHU Toulouse sjukhuset.<\/p>\n<p>\u00a0&#34;Det g\u00f6r mig v\u00e4ldigt glad att CHU Toulouse introducerar tv\u00e5 program i \u00e5r med hj\u00e4lp av XVIVOs teknologier. Jag skulle s\u00e4ga att det \u00e4r en global trend att sjukhus etablerar program f\u00f6r maskinperfusion f\u00f6r alla st\u00f6rre organ. Kompletta centrum f\u00f6r perfusion av lever, lungor, njurar och hj\u00e4rtan h\u00e5ller p\u00e5 att s\u00e4ttas upp runt om i v\u00e4rlden, och de beh\u00f6vs. Till exempel anv\u00e4ndes under 2020 endast 16 procent av alla tillg\u00e4ngliga donerade lungor. Maskinperfusion kommer att \u00e4ndra den siffran&#34;, s\u00e4ger Dag Anderson, VD f\u00f6r XVIVO.<br \/>\u00a0<\/p>\n<p>19 maj, 2022<br \/>G\u00f6teborg<br \/>Dag Andersson, CEO<br \/>XVIVO Perfusion AB (publ)<\/p>\n<hr\/>\n<p><a href=\"http:\/\/#_ftnref1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a> van Leeuwen, O.B., et al., Sequential Hypothermic and Normothermic Machine Perfusion Enables Safe Transplantation of High-risk Donor Livers. Am J Transplant, 2022<\/p>\n<\/div>\n<div class=\"mfn-footer\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, VD, +46 31-788 21 50,\u00a0dag.andersson@xvivogroup.com<br \/>Kristoffer\u00a0Nordstr\u00f6m,\u00a0CFO, +46 73-519 21 64,\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><\/p>\n<hr\/>\n<p>XVIVO grundades 1998 och \u00e4r ett medicintekniskt f\u00f6retag dedikerat till att f\u00f6rl\u00e4nga livet f\u00f6r donerade organ s\u00e5 att transplantationsteam runt om i v\u00e4rlden kan r\u00e4dda fler liv. V\u00e5ra l\u00f6sningar g\u00f6r det m\u00f6jligt f\u00f6r ledande kliniker och forskare att t\u00e4nja p\u00e5 gr\u00e4nserna f\u00f6r transplantationsmedicin.\u00a0XVIVO har sitt huvudkontor i G\u00f6teborg och har kontor och forskningsanl\u00e4ggningar p\u00e5 tv\u00e5 kontinenter. Bolaget \u00e4r noterat p\u00e5 Nasdaq Stockholm\u00a0och handlas under symbolen XVIVO. Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivogroup.com\/us<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/b65844d3-5efd-4770-b4d8-3061f04ee908\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier.pdf\" target=\"_blank\" rel=\"nofollow noopener\">CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sjukhuset CHU Toulouse i Frankrike har nu introducerat program f\u00f6r maskinperfusion f\u00f6r b\u00e5de lever och lunga. I och med det&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2710","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Sjukhuset CHU Toulouse i Frankrike har nu introducerat program f\u00f6r maskinperfusion f\u00f6r b\u00e5de lever och lunga. I och med det...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\\\/\",\"name\":\"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-05-19T13:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/","og_locale":"en_US","og_type":"article","og_title":"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO","og_description":"Sjukhuset CHU Toulouse i Frankrike har nu introducerat program f\u00f6r maskinperfusion f\u00f6r b\u00e5de lever och lunga. I och med det...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/","name":"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-05-19T13:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"CHU Toulouse i Frankrike introducerar program f\u00f6r maskinperfusion f\u00f6r lever och lunga med hj\u00e4lp av XVIVOs teknologier"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}